Veterans More Likely to Get Genetic Testing with In-Person Consults
A study led by Dr. Kara Maxwell, Men & BRCA Program Director, showed that veterans, particularly those who identify as Black, were more likely to get germline genetic cancer testing within an in-person nurse-led program.
What You Should Know About Genetic Testing and How it Can Save Lives
Jacquelyn Powers, MS, LCGC, associate director of Genetic Counseling at the Basser Center for BRCA, explained how genetic counseling and testing can identify cancer risk and help prevent or catch it early.
Eradicate Breast Cancer? The Hunt for a Vaccine Looks Promising
Led by Susan M. Domchek, MD, executive director of the Basser Center, the arrival of several breast cancer vaccine studies is an encouraging sign of the progress researchers are making in harnessing the immune system of preventing cancer.
Prostate Cancer Foundation-Funded Study Sheds Light on Improving Access to Precision Oncology Care for U.S. Veterans with Prostate Cancer
Research led by Kara Maxwell, MD, PhD, the director of the Men & BRCA Program, finds an embedded on-site genetics nurse can help reduce barriers to germline testing and improve genetic care for at-risk patients and families.
Six Warning Signs of Ovarian Cancer
“Ovarian cancer is often said to be a silent killer because it doesn’t have early symptoms, when in fact it does have symptoms..." explained Ronny Drapkin, MD, PhD, director of Gynecologic Cancer Research in the Basser Center.
New Hope for Breast Cancer Survivors: Study Finds a Break in Hormone Suppression Therapy to Bear Children Is Relatively Safe
A study found that allowing a break in hormone suppression therapy to allow breast cancer survivors the chance to get pregnant & breastfeed didn't appear to increase the risk of cancer recurring.
BRCA Mutations in Men: Three Things to Know
Learn what men should know about BRCA gene mutations from Kara Maxwell, MD, PhD, director of the Men & BRCA Program at the Basser Center for BRCA.
AACR Annual Meeting Highlights Showcased in Final Plenary Session
During the final session of the AACR Annual Meeting 2023, Program Committee Chair Robert H. Vonderheide, MD, DPhil, director of the ACC, reviewed significant highlights and themes from the meeting, “We've made progress and we have a lot more to do."
Next-Generation Cancer Therapies Will Reshape Cancer Treatment in the Coming Years
Gregory R. Bowman, PhD, the first researcher funded by the Basser Cancer Interception Institute (BCII), shared his team’s work using a neural network to find hidden pockets in proteins that could potentially be targeted with drugs to treat cancer.
Broadening Cancer Screening with Whole-Exome Sequencing
A retrospective analysis presented at the 2023 AACR Annual Meeting showed that whole-exome sequencing is an effective tool to identify people with hereditary cancer-predisposing conditions who would not meet current criteria for preventive screening.